25 XP   0   0   10

Guanhao Biotech Co Ltd
Buy, Hold or Sell?

Let's analyse Guanhao Biotech Co Ltd together

PenkeI guess you are interested in Guanhao Biotech Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Guanhao Biotech Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Guanhao Biotech Co Ltd

I send you an email if I find something interesting about Guanhao Biotech Co Ltd.

Quick analysis of Guanhao Biotech Co Ltd (30 sec.)










What can you expect buying and holding a share of Guanhao Biotech Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
94.9%

What is your share worth?

Current worth
¥1.72
Expected worth in 1 year
¥1.82
How sure are you?
76.9%

+ What do you gain per year?

Total Gains per Share
¥0.10
Return On Investment
1.1%

For what price can you sell your share?

Current Price per Share
¥8.85
Expected price per share
¥7.48 - ¥12.40
How sure are you?
50%

1. Valuation of Guanhao Biotech Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥8.85

Intrinsic Value Per Share

¥-11.67 - ¥1.01

Total Value Per Share

¥-9.95 - ¥2.73

2. Growth of Guanhao Biotech Co Ltd (5 min.)




Is Guanhao Biotech Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$63m$76.6m-$12.8m-20.1%

How much money is Guanhao Biotech Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$1m-$10.6m$11.7m1,092.8%
Net Profit Margin7.1%-98.2%--

How much money comes from the company's main activities?

3. Financial Health of Guanhao Biotech Co Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#450 / 1016

Most Revenue
#270 / 1016

Most Profit
#147 / 1016

Most Efficient
#129 / 1016

What can you expect buying and holding a share of Guanhao Biotech Co Ltd? (5 min.)

Welcome investor! Guanhao Biotech Co Ltd's management wants to use your money to grow the business. In return you get a share of Guanhao Biotech Co Ltd.

What can you expect buying and holding a share of Guanhao Biotech Co Ltd?

First you should know what it really means to hold a share of Guanhao Biotech Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Guanhao Biotech Co Ltd is ¥8.85. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Guanhao Biotech Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Guanhao Biotech Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥1.72. Based on the TTM, the Book Value Change Per Share is ¥0.02 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.30 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Guanhao Biotech Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps-0.01-0.1%0.000.0%-0.03-0.3%-0.01-0.2%0.000.0%
Usd Book Value Change Per Share-0.01-0.1%0.000.0%-0.04-0.5%-0.02-0.2%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-0.1%0.000.0%-0.04-0.5%-0.02-0.2%0.000.0%
Usd Price Per Share1.87-1.91-1.73-2.36-3.45-
Price to Earnings Ratio-87.56-38.80-31.90-17.88-109.86-
Price-to-Total Gains Ratio-235.94-238.22-107.11-201.63-361.19-
Price to Book Ratio7.88-7.93-6.10-6.69-9.70-
Price-to-Total Gains Ratio-235.94-238.22-107.11-201.63-361.19-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.22307
Number of shares817
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.00-0.02
Usd Total Gains Per Share0.00-0.02
Gains per Quarter (817 shares)2.83-13.17
Gains per Year (817 shares)11.32-52.70
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
111115-57-63
21221210-115-116
32322314-172-169
42433419-230-222
53544524-287-275
63655629-345-328
74766733-402-381
84867838-460-434
95978943-517-487
10510810048-575-540

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%10.02.00.083.3%16.04.00.080.0%34.04.01.087.2%46.04.01.090.2%
Book Value Change Per Share3.01.00.075.0%8.04.00.066.7%13.07.00.065.0%26.013.00.066.7%36.015.00.070.6%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%37.00.02.094.9%43.00.08.084.3%
Total Gains per Share3.01.00.075.0%8.04.00.066.7%14.06.00.070.0%30.09.00.076.9%42.09.00.082.4%

Fundamentals of Guanhao Biotech Co Ltd

About Guanhao Biotech Co Ltd

Guanhao Biotech Co.,Ltd. develops, manufactures, and markets regenerative medicines and life sciences products in China. It offers NormalGEN, a dura repair patch; GrandNeuro, a dura repair patch; ThormalGEN, a surgical patch; DermalGEN, a wound dressing product; IREAL breast patch; and Youvision corneal graft, as well as license in intraocular lenses. Its products can be used in neurosurgery, thoracic surgery, ophthalmology, dermatology, orthopedics, cosmetology, and other areas. The company was founded in 1999 and is headquartered in Guangzhou, China.

Fundamental data was last updated by Penke on 2024-04-16 13:26:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Guanhao Biotech Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Guanhao Biotech Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Guanhao Biotech Co Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -10.8% means that ¥-0.11 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Guanhao Biotech Co Ltd:

  • The MRQ is -10.8%. The company is making a huge loss. -2
  • The TTM is 7.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ-10.8%TTM7.1%-17.9%
TTM7.1%YOY-98.2%+105.2%
TTM7.1%5Y-32.4%+39.5%
5Y-32.4%10Y-7.4%-25.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.8%-199.6%+188.8%
TTM7.1%-213.0%+220.1%
YOY-98.2%-279.3%+181.1%
5Y-32.4%-438.4%+406.0%
10Y-7.4%-605.5%+598.1%
1.1.2. Return on Assets

Shows how efficient Guanhao Biotech Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Guanhao Biotech Co Ltd to the Biotechnology industry mean.
  • -1.5% Return on Assets means that Guanhao Biotech Co Ltd generated ¥-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Guanhao Biotech Co Ltd:

  • The MRQ is -1.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 1.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ-1.5%TTM1.1%-2.6%
TTM1.1%YOY-10.3%+11.4%
TTM1.1%5Y-3.4%+4.5%
5Y-3.4%10Y-1.0%-2.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.5%-13.5%+12.0%
TTM1.1%-12.9%+14.0%
YOY-10.3%-11.8%+1.5%
5Y-3.4%-14.1%+10.7%
10Y-1.0%-16.0%+15.0%
1.1.3. Return on Equity

Shows how efficient Guanhao Biotech Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Guanhao Biotech Co Ltd to the Biotechnology industry mean.
  • -2.0% Return on Equity means Guanhao Biotech Co Ltd generated ¥-0.02 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Guanhao Biotech Co Ltd:

  • The MRQ is -2.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is 1.5%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-2.0%TTM1.5%-3.5%
TTM1.5%YOY-14.9%+16.4%
TTM1.5%5Y-5.2%+6.7%
5Y-5.2%10Y-1.8%-3.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.0%-16.9%+14.9%
TTM1.5%-16.1%+17.6%
YOY-14.9%-15.1%+0.2%
5Y-5.2%-19.9%+14.7%
10Y-1.8%-20.9%+19.1%

1.2. Operating Efficiency of Guanhao Biotech Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Guanhao Biotech Co Ltd is operating .

  • Measures how much profit Guanhao Biotech Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Guanhao Biotech Co Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Guanhao Biotech Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM8.7%-8.7%
TTM8.7%YOY5.3%+3.4%
TTM8.7%5Y-9.4%+18.1%
5Y-9.4%10Y-4.8%-4.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--295.1%+295.1%
TTM8.7%-225.8%+234.5%
YOY5.3%-288.4%+293.7%
5Y-9.4%-477.4%+468.0%
10Y-4.8%-625.6%+620.8%
1.2.2. Operating Ratio

Measures how efficient Guanhao Biotech Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.28 means that the operating costs are ¥1.28 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Guanhao Biotech Co Ltd:

  • The MRQ is 1.282. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.077. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.282TTM1.077+0.205
TTM1.077YOY1.120-0.042
TTM1.0775Y1.151-0.073
5Y1.15110Y0.674+0.477
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2823.090-1.808
TTM1.0773.264-2.187
YOY1.1203.783-2.663
5Y1.1515.679-4.528
10Y0.6747.894-7.220

1.3. Liquidity of Guanhao Biotech Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Guanhao Biotech Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.55 means the company has ¥1.55 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Guanhao Biotech Co Ltd:

  • The MRQ is 1.547. The company is able to pay all its short-term debts. +1
  • The TTM is 1.751. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.547TTM1.751-0.204
TTM1.751YOY1.659+0.093
TTM1.7515Y1.638+0.113
5Y1.63810Y0.840+0.798
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5473.914-2.367
TTM1.7514.220-2.469
YOY1.6595.388-3.729
5Y1.6386.045-4.407
10Y0.8406.406-5.566
1.3.2. Quick Ratio

Measures if Guanhao Biotech Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Guanhao Biotech Co Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 0.35 means the company can pay off ¥0.35 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Guanhao Biotech Co Ltd:

  • The MRQ is 0.354. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.491. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.354TTM0.491-0.137
TTM0.491YOY0.481+0.010
TTM0.4915Y0.507-0.016
5Y0.50710Y0.713-0.206
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3543.572-3.218
TTM0.4913.998-3.507
YOY0.4815.390-4.909
5Y0.5075.969-5.462
10Y0.7136.287-5.574

1.4. Solvency of Guanhao Biotech Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Guanhao Biotech Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Guanhao Biotech Co Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.33 means that Guanhao Biotech Co Ltd assets are financed with 32.8% credit (debt) and the remaining percentage (100% - 32.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Guanhao Biotech Co Ltd:

  • The MRQ is 0.328. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.325. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.328TTM0.325+0.003
TTM0.325YOY0.346-0.021
TTM0.3255Y0.342-0.017
5Y0.34210Y0.267+0.075
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3280.336-0.008
TTM0.3250.334-0.009
YOY0.3460.269+0.077
5Y0.3420.366-0.024
10Y0.2670.390-0.123
1.4.2. Debt to Equity Ratio

Measures if Guanhao Biotech Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Guanhao Biotech Co Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 42.7% means that company has ¥0.43 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Guanhao Biotech Co Ltd:

  • The MRQ is 0.427. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.428. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.427TTM0.428-0.001
TTM0.428YOY0.489-0.061
TTM0.4285Y0.501-0.073
5Y0.50110Y0.381+0.120
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4270.382+0.045
TTM0.4280.396+0.032
YOY0.4890.335+0.154
5Y0.5010.434+0.067
10Y0.3810.465-0.084

2. Market Valuation of Guanhao Biotech Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Guanhao Biotech Co Ltd generates.

  • Above 15 is considered overpriced but always compare Guanhao Biotech Co Ltd to the Biotechnology industry mean.
  • A PE ratio of -87.56 means the investor is paying ¥-87.56 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Guanhao Biotech Co Ltd:

  • The EOD is -57.148. Based on the earnings, the company is expensive. -2
  • The MRQ is -87.563. Based on the earnings, the company is expensive. -2
  • The TTM is 38.800. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD-57.148MRQ-87.563+30.415
MRQ-87.563TTM38.800-126.363
TTM38.800YOY31.903+6.897
TTM38.8005Y17.878+20.922
5Y17.87810Y109.859-91.982
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-57.148-2.259-54.889
MRQ-87.563-2.569-84.994
TTM38.800-2.664+41.464
YOY31.903-4.120+36.023
5Y17.878-6.258+24.136
10Y109.859-6.171+116.030
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Guanhao Biotech Co Ltd:

  • The EOD is -15.981. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -24.486. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 100.720. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-15.981MRQ-24.486+8.505
MRQ-24.486TTM100.720-125.206
TTM100.720YOY38.928+61.791
TTM100.7205Y58.363+42.356
5Y58.36310Y-71.927+130.290
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-15.981-2.924-13.057
MRQ-24.486-3.246-21.240
TTM100.720-3.488+104.208
YOY38.928-5.620+44.548
5Y58.363-8.315+66.678
10Y-71.927-8.826-63.101
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Guanhao Biotech Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 7.88 means the investor is paying ¥7.88 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Guanhao Biotech Co Ltd:

  • The EOD is 5.143. Based on the equity, the company is overpriced. -1
  • The MRQ is 7.880. Based on the equity, the company is overpriced. -1
  • The TTM is 7.926. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.143MRQ7.880-2.737
MRQ7.880TTM7.926-0.046
TTM7.926YOY6.103+1.823
TTM7.9265Y6.694+1.232
5Y6.69410Y9.699-3.005
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD5.1431.851+3.292
MRQ7.8802.090+5.790
TTM7.9262.095+5.831
YOY6.1032.844+3.259
5Y6.6943.466+3.228
10Y9.6993.815+5.884
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Guanhao Biotech Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0580.024-343%-0.299+414%-0.127+119%-0.004-93%
Book Value Per Share--1.7211.741-1%2.091-18%2.663-35%3.060-44%
Current Ratio--1.5471.751-12%1.659-7%1.638-6%0.840+84%
Debt To Asset Ratio--0.3280.325+1%0.346-5%0.342-4%0.267+23%
Debt To Equity Ratio--0.4270.4280%0.489-13%0.501-15%0.381+12%
Dividend Per Share--0.0010.001-39%0.003-80%0.011-93%0.026-97%
Eps---0.0390.029-232%-0.197+410%-0.099+155%-0.025-35%
Free Cash Flow Per Share---0.1380.000-63628%0.028-593%0.064-317%0.058-340%
Free Cash Flow To Equity Per Share---0.138-0.017-88%-0.039-72%0.010-1463%0.178-178%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.974+3%
Intrinsic Value_10Y_max--1.011--------
Intrinsic Value_10Y_min---11.673--------
Intrinsic Value_1Y_max--0.212--------
Intrinsic Value_1Y_min---0.045--------
Intrinsic Value_3Y_max--0.553--------
Intrinsic Value_3Y_min---1.110--------
Intrinsic Value_5Y_max--0.792--------
Intrinsic Value_5Y_min---3.235--------
Market Cap2346630600.000-53%3595515360.0003660478580.000-2%3312461330.000+9%4524285252.750-21%6623424197.308-46%
Net Profit Margin---0.1080.071-252%-0.982+811%-0.324+201%-0.074-31%
Operating Margin---0.087-100%0.053-100%-0.0940%-0.0480%
Operating Ratio--1.2821.077+19%1.120+15%1.151+11%0.674+90%
Pb Ratio5.143-53%7.8807.926-1%6.103+29%6.694+18%9.699-19%
Pe Ratio-57.148+35%-87.56338.800-326%31.903-374%17.878-590%109.859-180%
Price Per Share8.850-53%13.56013.805-2%12.493+9%17.061-21%24.978-46%
Price To Free Cash Flow Ratio-15.981+35%-24.486100.720-124%38.928-163%58.363-142%-71.927+194%
Price To Total Gains Ratio-153.989+35%-235.943238.218-199%107.105-320%201.632-217%361.191-165%
Quick Ratio--0.3540.491-28%0.481-26%0.507-30%0.713-50%
Return On Assets---0.0150.011-235%-0.103+582%-0.034+122%-0.010-32%
Return On Equity---0.0200.015-231%-0.149+656%-0.052+163%-0.018-9%
Total Gains Per Share---0.0570.025-329%-0.296+414%-0.117+103%0.022-362%
Usd Book Value--63055165.96363811450.558-1%76629839.714-18%97608095.576-35%112151987.395-44%
Usd Book Value Change Per Share---0.0080.003-343%-0.041+414%-0.018+119%-0.001-93%
Usd Book Value Per Share--0.2380.241-1%0.289-18%0.368-35%0.423-44%
Usd Dividend Per Share--0.0000.000-39%0.000-80%0.001-93%0.004-97%
Usd Eps---0.0050.004-232%-0.027+410%-0.014+155%-0.003-35%
Usd Free Cash Flow---5073284.5607985.954-63628%1029904.773-593%2342948.661-317%2059918.046-346%
Usd Free Cash Flow Per Share---0.0190.000-63628%0.004-593%0.009-317%0.008-340%
Usd Free Cash Flow To Equity Per Share---0.019-0.002-88%-0.005-72%0.001-1463%0.025-178%
Usd Market Cap324304348.920-53%496900222.752505878139.756-2%457782155.806+9%625256221.930-21%915357224.068-46%
Usd Price Per Share1.223-53%1.8741.908-2%1.726+9%2.358-21%3.452-46%
Usd Profit---1418696.0651071250.341-232%-10635756.491+650%-4297182.290+203%-1271794.602-10%
Usd Revenue--13160742.29813964373.990-6%13035197.241+1%14823948.517-11%12894535.979+2%
Usd Total Gains Per Share---0.0080.003-329%-0.041+414%-0.016+103%0.003-362%
 EOD+3 -5MRQTTM+5 -30YOY+18 -175Y+15 -1910Y+6 -29

3.2. Fundamental Score

Let's check the fundamental score of Guanhao Biotech Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-57.148
Price to Book Ratio (EOD)Between0-15.143
Net Profit Margin (MRQ)Greater than0-0.108
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.354
Current Ratio (MRQ)Greater than11.547
Debt to Asset Ratio (MRQ)Less than10.328
Debt to Equity Ratio (MRQ)Less than10.427
Return on Equity (MRQ)Greater than0.15-0.020
Return on Assets (MRQ)Greater than0.05-0.015
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Guanhao Biotech Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.821
Ma 20Greater thanMa 5010.270
Ma 50Greater thanMa 10010.163
Ma 100Greater thanMa 20011.797
OpenGreater thanClose8.880
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets678,595
Total Liabilities222,335
Total Stockholder Equity520,594
 As reported
Total Liabilities 222,335
Total Stockholder Equity+ 520,594
Total Assets = 678,595

Assets

Total Assets678,595
Total Current Assets267,278
Long-term Assets411,317
Total Current Assets
Cash And Cash Equivalents 105,136
Net Receivables 61,143
Inventory 71,601
Other Current Assets 8,818
Total Current Assets  (as reported)267,278
Total Current Assets  (calculated)246,699
+/- 20,579
Long-term Assets
Property Plant Equipment 252,039
Intangible Assets 99,134
Long-term Assets Other 391
Long-term Assets  (as reported)411,317
Long-term Assets  (calculated)351,564
+/- 59,753

Liabilities & Shareholders' Equity

Total Current Liabilities172,716
Long-term Liabilities49,618
Total Stockholder Equity520,594
Total Current Liabilities
Short Long Term Debt 24,519
Accounts payable 29,323
Other Current Liabilities 1,311
Total Current Liabilities  (as reported)172,716
Total Current Liabilities  (calculated)55,154
+/- 117,563
Long-term Liabilities
Long term Debt 12,015
Capital Lease Obligations Min Short Term Debt12,060
Long-term Liabilities  (as reported)49,618
Long-term Liabilities  (calculated)24,075
+/- 25,544
Total Stockholder Equity
Total Stockholder Equity (as reported)520,594
Total Stockholder Equity (calculated)0
+/- 520,594
Other
Capital Stock265,156
Common Stock Shares Outstanding 265,156
Net Invested Capital 557,128
Net Working Capital 94,562
Property Plant and Equipment Gross 418,382



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312009-12-312008-12-31
> Total Assets 
61,820
122,298
236,021
233,400
497,323
485,945
496,064
524,381
525,315
546,387
541,989
537,814
533,162
539,639
572,518
574,862
566,701
590,243
619,537
655,106
656,202
714,279
807,024
820,358
943,956
1,717,650
1,636,693
1,609,685
1,613,412
1,649,340
1,718,167
1,661,388
1,705,608
1,684,992
1,618,327
1,588,079
1,584,370
1,149,348
1,173,736
1,178,546
1,328,235
1,134,728
1,121,379
1,159,926
1,136,804
1,098,737
1,108,066
794,725
794,938
670,209
693,671
682,761
680,431
678,595
678,595680,431682,761693,671670,209794,938794,7251,108,0661,098,7371,136,8041,159,9261,121,3791,134,7281,328,2351,178,5461,173,7361,149,3481,584,3701,588,0791,618,3271,684,9921,705,6081,661,3881,718,1671,649,3401,613,4121,609,6851,636,6931,717,650943,956820,358807,024714,279656,202655,106619,537590,243566,701574,862572,518539,639533,162537,814541,989546,387525,315524,381496,064485,945497,323233,400236,021122,29861,820
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
413,000
386,530
405,597
416,278
448,889
453,944
616,152
438,034
411,838
463,900
448,481
435,414
453,323
362,957
343,057
298,889
324,503
316,139
309,400
267,278
267,278309,400316,139324,503298,889343,057362,957453,323435,414448,481463,900411,838438,034616,152453,944448,889416,278405,597386,530413,0000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
93,130
94,455
106,002
139,573
168,647
187,542
337,960
156,202
132,140
173,701
160,295
159,308
177,024
159,234
137,913
126,280
127,319
136,297
131,686
105,136
105,136131,686136,297127,319126,280137,913159,234177,024159,308160,295173,701132,140156,202337,960187,542168,647139,573106,00294,45593,1300000000000000000000000000000000000
       Net Receivables 
8,045
17,381
42,131
50,741
45,754
38,880
36,339
41,932
44,888
52,108
36,150
37,725
41,829
43,347
32,183
33,162
33,540
37,013
33,861
33,772
31,651
59,042
69,815
78,696
58,469
91,892
113,573
121,937
143,027
229,347
171,662
138,165
155,257
207,550
175,204
156,231
150,871
151,397
148,490
139,422
134,713
130,714
136,174
142,425
124,320
117,750
127,827
119,034
105,663
71,976
110,453
94,494
77,732
61,143
61,14377,73294,494110,45371,976105,663119,034127,827117,750124,320142,425136,174130,714134,713139,422148,490151,397150,871156,231175,204207,550155,257138,165171,662229,347143,027121,937113,57391,89258,46978,69669,81559,04231,65133,77233,86137,01333,54033,16232,18343,34741,82937,72536,15052,10844,88841,93236,33938,88045,75450,74142,13117,3818,045
       Other Current Assets 
12
1
13,855
20,117
18,224
15,710
15,275
8,199
12,675
6,513
3,461
10,785
9,460
18,553
2,522
3,035
2,795
3,124
1,592
2,784
1,137
6,206
14,101
13,198
4,256
1,423
3,779
2,161
7,898
3,724
13,764
15,663
18,313
16,319
27,111
17,428
16,778
26,008
25,019
25,354
31,677
24,218
19,376
19,838
26,161
17,807
25,500
21,295
33,520
30,216
19,102
15,518
1,824
8,818
8,8181,82415,51819,10230,21633,52021,29525,50017,80726,16119,83819,37624,21831,67725,35425,01926,00816,77817,42827,11116,31918,31315,66313,7643,7247,8982,1613,7791,4234,25613,19814,1016,2061,1372,7841,5923,1242,7953,0352,52218,5539,46010,7853,4616,51312,6758,19915,27515,71018,22420,11713,855112
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,205,327
1,201,549
1,178,773
733,069
724,847
724,602
712,083
696,694
709,540
696,026
688,323
663,323
654,742
431,768
451,881
371,320
369,168
366,622
371,031
411,317
411,317371,031366,622369,168371,320451,881431,768654,742663,323688,323696,026709,540696,694712,083724,602724,847733,0691,178,7731,201,5491,205,3270000000000000000000000000000000000
       Property Plant Equipment 
4,304
26,713
90,795
73,276
101,774
106,423
134,104
135,887
165,912
188,410
222,755
205,439
220,808
206,165
227,033
209,985
209,257
214,312
212,389
210,382
210,231
206,089
205,297
203,170
199,795
196,940
197,178
193,079
188,645
229,716
242,112
242,088
263,163
266,536
249,710
244,642
241,047
236,511
232,139
228,334
224,709
220,633
238,794
243,451
239,107
245,536
239,080
233,130
222,524
214,598
215,160
214,290
219,704
252,039
252,039219,704214,290215,160214,598222,524233,130239,080245,536239,107243,451238,794220,633224,709228,334232,139236,511241,047244,642249,710266,536263,163242,088242,112229,716188,645193,079197,178196,940199,795203,170205,297206,089210,231210,382212,389214,312209,257209,985227,033206,165220,808205,439222,755188,410165,912135,887134,104106,423101,77473,27690,79526,7134,304
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,495
16,829
38,036
45,682
568,553
568,652
568,652
568,652
568,652
568,652
568,652
569,306
569,306
566,564
566,564
566,564
214,330
214,330
214,330
214,330
214,330
214,330
214,330
214,479
214,330
214,330
0
0
0
0
0
0
0
0000000214,330214,330214,479214,330214,330214,330214,330214,330214,330214,330566,564566,564566,564569,306569,306568,652568,652568,652568,652568,652568,652568,55345,68238,03616,82915,495000000000000000000000
       Intangible Assets 
31,198
39,407
17,682
37,549
16,944
37,340
16,217
42,158
17,722
42,668
16,635
44,656
15,169
48,262
22,549
38,114
37,209
47,938
47,294
46,639
57,283
71,243
74,848
94,257
100,159
621,263
619,638
617,830
616,381
614,555
620,443
618,548
617,497
616,016
128,836
113,085
125,115
89,490
87,594
85,291
82,702
79,657
77,734
75,761
73,739
72,364
72,213
73,845
105,432
103,095
100,954
99,443
99,316
99,134
99,13499,31699,443100,954103,095105,43273,84572,21372,36473,73975,76177,73479,65782,70285,29187,59489,490125,115113,085128,836616,016617,497618,548620,443614,555616,381617,830619,638621,263100,15994,25774,84871,24357,28346,63947,29447,93837,20938,11422,54948,26215,16944,65616,63542,66817,72242,15816,21737,34016,94437,54917,68239,40731,198
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,808
383
958
15,000
15,678
25,516
240,312
15,578
15,395
138
562
0
45
0
135
0
0
0
1,761
391
3911,761000135045056213815,39515,578240,31225,51615,67815,00095838316,8080000000000000000000000000000000000
> Total Liabilities 
24,808
45,345
91,029
86,165
93,230
73,091
63,271
79,227
87,716
101,879
87,884
76,069
76,348
73,372
74,361
66,742
61,740
71,331
87,925
78,705
84,403
123,217
186,406
190,862
299,121
322,430
201,520
161,129
172,238
184,276
505,245
485,115
585,323
553,844
465,542
437,820
428,222
445,212
457,898
445,844
589,899
418,068
388,674
410,857
372,845
350,575
339,060
289,836
281,772
239,329
236,986
220,460
208,747
222,335
222,335208,747220,460236,986239,329281,772289,836339,060350,575372,845410,857388,674418,068589,899445,844457,898445,212428,222437,820465,542553,844585,323485,115505,245184,276172,238161,129201,520322,430299,121190,862186,406123,21784,40378,70587,92571,33161,74066,74274,36173,37276,34876,06987,884101,87987,71679,22763,27173,09193,23086,16591,02945,34524,808
   > Total Current Liabilities 
11,122
5,939
41,892
35,904
44,362
24,255
16,801
22,633
32,330
42,508
33,225
23,381
25,993
25,119
27,879
21,784
18,305
29,647
30,299
22,495
29,223
68,866
136,414
142,437
248,534
266,352
150,709
110,260
125,094
134,612
296,428
278,552
364,129
320,577
255,758
230,313
223,331
272,426
286,928
299,798
448,424
302,703
254,208
292,387
260,241
262,270
252,240
215,008
218,854
188,989
188,625
173,011
161,918
172,716
172,716161,918173,011188,625188,989218,854215,008252,240262,270260,241292,387254,208302,703448,424299,798286,928272,426223,331230,313255,758320,577364,129278,552296,428134,612125,094110,260150,709266,352248,534142,437136,41468,86629,22322,49530,29929,64718,30521,78427,87925,11925,99323,38133,22542,50832,33022,63316,80124,25544,36235,90441,8925,93911,122
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
148,000
138,000
147,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000147,000138,000148,0000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
148,000
138,000
147,000
133,197
183,236
171,220
153,192
102,877
72,594
72,335
52,000
51,564
51,063
50,557
50,039
49,048
48,047
36,031
25,517
24,519
24,51925,51736,03148,04749,04850,03950,55751,06351,56452,00072,33572,594102,877153,192171,220183,236133,197147,000138,000148,0000000000000000000000000000000000000
       Accounts payable 
21
55
84
167
146
115
121
267
10,146
531
131
202
196
261
218
106
162
242
57
328
228
171
173
523
651
3,572
784
1,492
4,666
7,334
3,748
6,227
14,054
7,475
10,400
14,584
4,197
12,929
2,066
1,934
1,535
3,006
2,568
1,900
2,425
1,881
1,523
2,013
1,801
2,164
4,597
2,607
3,601
29,323
29,3233,6012,6074,5972,1641,8012,0131,5231,8812,4251,9002,5683,0061,5351,9342,06612,9294,19714,58410,4007,47514,0546,2273,7487,3344,6661,4927843,5726515231731712283285724216210621826119620213153110,146267121115146167845521
       Other Current Liabilities 
11,101
5,884
41,808
35,737
44,216
24,140
16,680
22,366
22,184
41,977
33,094
23,179
25,797
24,858
27,661
21,679
18,143
29,405
30,242
22,167
28,995
18,695
36,240
41,913
47,883
112,780
69,924
48,768
60,428
62,278
127,679
107,325
185,075
153,102
0
0
69,718
48,898
64,153
76,437
253,052
120,971
136,784
142,041
126,876
120,262
126,262
100,075
110,282
1,967
119,645
71,617
851
1,311
1,31185171,617119,6451,967110,282100,075126,262120,262126,876142,041136,784120,971253,05276,43764,15348,89869,71800153,102185,075107,325127,67962,27860,42848,76869,924112,78047,88341,91336,24018,69528,99522,16730,24229,40518,14321,67927,66124,85825,79723,17933,09441,97722,18422,36616,68024,14044,21635,73741,8085,88411,101
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
209,784
207,507
204,891
172,785
170,970
146,046
141,475
115,365
134,466
118,470
112,603
88,305
86,820
74,828
62,917
50,340
48,361
47,448
46,830
49,618
49,61846,83047,44848,36150,34062,91774,82886,82088,305112,603118,470134,466115,365141,475146,046170,970172,785204,891207,507209,7840000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-148,000
-138,000
-147,000
0
0
0
0
0
18,655
28,181
25,291
35,620
36,103
31,831
28,227
22,519
20,835
19,653
20,439
12,060
12,06020,43919,65320,83522,51928,22731,83136,10335,62025,29128,18118,65500000-147,000-138,000-148,0000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
149,600
144,600
144,600
104,600
104,600
79,600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000079,600104,600104,600144,600144,600149,6000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
125,643
72,042
68,020
35,724
34,476
33,365
31,660
29,819
28,720
22,762
23,529
23,658
24,964
27,731
27,106
23,578
23,445
23,277
0
0
0023,27723,44523,57827,10627,73124,96423,65823,52922,76228,72029,81931,66033,36534,47635,72468,02072,042125,6430000000000000000000000000000000000
> Total Stockholder Equity
37,012
76,953
144,992
147,236
404,093
412,854
432,793
445,154
437,599
444,508
454,106
461,746
456,815
466,266
498,157
508,120
504,961
518,912
531,612
540,468
536,733
552,122
581,045
587,236
596,118
1,347,162
1,388,145
1,398,957
1,401,682
1,426,154
1,165,146
1,164,344
1,112,444
1,124,545
1,155,027
1,155,838
1,163,370
711,406
724,238
740,169
746,329
730,268
747,611
769,114
788,456
783,921
805,181
543,820
554,435
485,310
509,156
517,269
529,252
520,594
520,594529,252517,269509,156485,310554,435543,820805,181783,921788,456769,114747,611730,268746,329740,169724,238711,4061,163,3701,155,8381,155,0271,124,5451,112,4441,164,3441,165,1461,426,1541,401,6821,398,9571,388,1451,347,162596,118587,236581,045552,122536,733540,468531,612518,912504,961508,120498,157466,266456,815461,746454,106444,508437,599445,154432,793412,854404,093147,236144,99276,95337,012
   Common Stock
31,628
41,800
45,800
45,800
61,100
61,100
61,100
61,100
122,200
122,200
122,200
122,200
122,200
122,200
123,445
123,445
123,445
123,445
123,595
123,498
246,995
246,995
246,995
246,768
246,768
265,799
265,799
265,754
265,156
265,156
265,156
265,156
265,156
265,156
265,156
265,156
265,156
265,156
265,156
265,156
265,156
265,156
265,156
265,156
265,156
265,156
265,156
265,156
265,156
265,156
265,156
265,156
0
0
00265,156265,156265,156265,156265,156265,156265,156265,156265,156265,156265,156265,156265,156265,156265,156265,156265,156265,156265,156265,156265,156265,156265,156265,156265,754265,799265,799246,768246,768246,995246,995246,995123,498123,595123,445123,445123,445123,445122,200122,200122,200122,200122,200122,20061,10061,10061,10061,10045,80045,80041,80031,628
   Retained Earnings 
3,910
16,885
45,992
46,865
58,002
66,894
81,026
93,387
86,256
93,146
99,244
106,904
102,051
111,524
123,552
149,998
145,318
157,708
179,394
188,411
184,110
198,116
230,420
238,762
245,860
260,091
295,791
307,562
300,277
325,948
314,122
321,613
279,200
298,373
292,084
290,841
296,285
-142,602
-131,053
-115,635
-105,741
-96,007
-77,760
-54,783
-35,229
-21,570
209
-265,556
-253,155
-329,407
-307,292
-298,664
-331,987
-345,478
-345,478-331,987-298,664-307,292-329,407-253,155-265,556209-21,570-35,229-54,783-77,760-96,007-105,741-115,635-131,053-142,602296,285290,841292,084298,373279,200321,613314,122325,948300,277307,562295,791260,091245,860238,762230,420198,116184,110188,411179,394157,708145,318149,998123,552111,524102,051106,90499,24493,14686,25693,38781,02666,89458,00246,86545,99216,8853,910
   Capital Surplus 000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000-4,354-4,354-8,664-8,664-8,664-8,664-14,006-14,006-14,006-14,006000000000000000000
   Other Stockholders Equity 00-49,491-48,976-50,707-55,279-53,494-57,898-57,378-39,184-38,972-37,498-37,897-10,999-7,265-7,779-9,061-5,863-7,951-10,0020000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue404,179
Cost of Revenue-84,367
Gross Profit319,812319,812
 
Operating Income (+$)
Gross Profit319,812
Operating Expense-348,956
Operating Income55,223-29,144
 
Operating Expense (+$)
Research Development44,504
Selling General Administrative188,209
Selling And Marketing Expenses0
Operating Expense348,956232,712
 
Net Interest Income (+$)
Interest Income1,503
Interest Expense-1,782
Other Finance Cost-1,547
Net Interest Income-1,826
 
Pretax Income (+$)
Operating Income55,223
Net Interest Income-1,826
Other Non-Operating Income Expenses0
Income Before Tax (EBT)32,08955,223
EBIT - interestExpense = -1,782
31,006
32,788
Interest Expense1,782
Earnings Before Interest and Taxes (EBIT)033,872
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax32,089
Tax Provision-11,017
Net Income From Continuing Ops21,07321,073
Net Income31,006
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net01,826
 

Technical Analysis of Guanhao Biotech Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Guanhao Biotech Co Ltd. The general trend of Guanhao Biotech Co Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Guanhao Biotech Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Guanhao Biotech Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 9.96 < 11.94 < 12.40.

The bearish price targets are: 7.48.

Tweet this
Guanhao Biotech Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Guanhao Biotech Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Guanhao Biotech Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Guanhao Biotech Co Ltd. The current macd is -0.46543802.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Guanhao Biotech Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Guanhao Biotech Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Guanhao Biotech Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Guanhao Biotech Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartGuanhao Biotech Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Guanhao Biotech Co Ltd. The current adx is 23.97.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Guanhao Biotech Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Guanhao Biotech Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Guanhao Biotech Co Ltd. The current sar is 10.01.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Guanhao Biotech Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Guanhao Biotech Co Ltd. The current rsi is 36.82. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Guanhao Biotech Co Ltd Daily Relative Strength Index (RSI) ChartGuanhao Biotech Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Guanhao Biotech Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Guanhao Biotech Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Guanhao Biotech Co Ltd Daily Stochastic Oscillator ChartGuanhao Biotech Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Guanhao Biotech Co Ltd. The current cci is -132.58529883.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Guanhao Biotech Co Ltd Daily Commodity Channel Index (CCI) ChartGuanhao Biotech Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Guanhao Biotech Co Ltd. The current cmo is -33.19519786.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Guanhao Biotech Co Ltd Daily Chande Momentum Oscillator (CMO) ChartGuanhao Biotech Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Guanhao Biotech Co Ltd. The current willr is -89.25925926.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Guanhao Biotech Co Ltd Daily Williams %R ChartGuanhao Biotech Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Guanhao Biotech Co Ltd.

Guanhao Biotech Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Guanhao Biotech Co Ltd. The current atr is 0.56548842.

Guanhao Biotech Co Ltd Daily Average True Range (ATR) ChartGuanhao Biotech Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Guanhao Biotech Co Ltd. The current obv is 30,667,142.

Guanhao Biotech Co Ltd Daily On-Balance Volume (OBV) ChartGuanhao Biotech Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Guanhao Biotech Co Ltd. The current mfi is 37.65.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Guanhao Biotech Co Ltd Daily Money Flow Index (MFI) ChartGuanhao Biotech Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Guanhao Biotech Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Guanhao Biotech Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Guanhao Biotech Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.821
Ma 20Greater thanMa 5010.270
Ma 50Greater thanMa 10010.163
Ma 100Greater thanMa 20011.797
OpenGreater thanClose8.880
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Guanhao Biotech Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Guanhao Biotech Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Guanhao Biotech Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Guanhao Biotech Co Ltd

I send you an email if I find something interesting about Guanhao Biotech Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Guanhao Biotech Co Ltd.

Receive notifications about Guanhao Biotech Co Ltd in your mailbox!